Stocks
Charles River Laboratories International, Inc.CRL
NYSEHealthcareLife Sciences Tools & Services$155.46+1.83%
Provides outsourced research and drug development services to pharmaceutical, biotechnology, and academic institutions, including preclinical testing, laboratory services, and research models used in early-stage drug discovery. The company plays a key role in the pharmaceutical R&D supply chain, sup...
Market Cap: $7.7B52W Range: $91.86 – $228.88
Congressional Interest in Charles River Laboratories International, Inc. (CRL)
7 members of Congress have disclosed 31 trades in Charles River Laboratories International, Inc. (CRL), a Healthcare company. The buy/sell breakdown shows 15 purchases versus 16 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
31
Unique Politicians
7
Buys
15
Sells
16
Who in Congress Is Trading CRL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-05 | Rohit Khanna | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |